Episode 8. Why LDL-C, Hemoglobin A1c, and Continuous Glucose Monitors Are Not Optimal Tests For Longevity

In today’s episode, we will be discussing the shortcomings and alternatives to some of the most commonly utilized tests for longevity and preventive medicine, including LDL cholesterol (LDL-C), Hemoglobin A1c (HbA1c), and Continuous Glucose Monitors (CGMs). With advancements in technology, there are now multiple laboratory tests that provide more accurate and useful information than LDL-C, HbA1c, or CGMs. Despite these improvements in testing, widespread awareness and adoption of these superior tests remain limited. The purpose of this podcast is to demonstrate the shortcomings of LDL-C, HbA1c, and CGMs. By examining alternative testing strategies, this podcast seeks to empower health conscious individuals and healthcare professionals in their ability to adopt more effective testing strategies for the prevention of disease and promotion of longevity. In summary,a normal LDL-C does not rule out the risk of cardiovascular disease, and thatnormal results from HbA1c and CGM data do not rule out the possibility of insulin resistance. Meanwhile, there are more effective testing strategies available to those who are seeking to optimize their health, likelihood of longevity, and ability to identify disease risk as early as possible.Link toOriginal Blog Post andReferences.Link toLPIR Score.Link toTriglyceride-Glucose Index (TyG Index).Link toHOMA-IR Calculator.